 |
|
July 8, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Jehee Suh, CEO, Inocras |
| In this
Q&A, Suh discusses what drew him to
Inocras, why whole-genome analysis is
approaching an inflection point, how
Inocras is building the evidence base for
broader clinical adoption, and what it
will take for whole-genome-based care to
become the new standard in oncology and
rare disease. More |
|
|
- Bayer, The University of Colorado Anschutz,
UCHealth, and Children’s Hospital Colorado:
Form Strategic Alliance to Advance Drug
Development and Clinical Trials More
- Cambrex, Snapdragon Chemistry, and Q1
Scientific: Recognized for Innovation and
Sustainability in Pharma More
- Cresilon: TRAUMAGEL Study Highlights
Sustained Hemorrhage Control and Tourniquet
Removal Without Rebleeding More
- Glucotrack: USPTO Notice of Allowance for
Patent Application Covering Its Implantable
CBGM Platform More
- OKYO Pharma: Positive Feedback From FDA Type
D Meeting and Accelerates Urcosimod Into
Global Phase 3 Pivotal Trial for Neuropathic
Corneal Pain More
- UroGen: FDA Clearance of the IND for
UGN-501, an Investigational Next-Generation
Oncolytic Virus for Non-Muscle Invasive
Bladder Cancer More
|
|
- BioPharmCatalyst Weekly Watchlist: Key PDUFA
and Regulatory Catalysts for the Next 6 Months
More
- MeiraGTx: $400 Million Strategic
Investment by Oberland Capital to Support
Development and Commercialization of
AAV2-hAQP1 and Botaretigene Sparoparvovec
(bota-vec)
More More
More*
More*
|
|
- A Decade on the Map: How Big4Bio’s
Regions Moved in GEN’s Top 10 Biopharma
Clusters, 2016–2026
More
- Big4Bio CEO Weekly Q&A: Jehee
Suh, CEO, Inocras More
- Episode 26-27 Biotech in the Balance
Podcast
- More on Bristol Laying Out KRAS Med
Krazati’s Stumble in Confirmatory Colorectal
Cancer Trial More
More*
- More on Compass Pathways Touting
Durability Data for Psilocybin Drug in
Depression Ahead of Year-End Filing
More* More*
More* More
- More on Whitehawk Swooping In for Five ADCs
via Development Deal With China’s Biocytogen More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- ZoBio: Expert Q&A More
|
|
- ICYMI: A View From the Trenches - Biotech
Series A in 2026 More
- Novartis Slashes New Jersey
Workforce Again, Cutting 322 Employees More
More
- OPPORTUNITY: Chief Executive Officer,
Cambridge, MA
More
- OPPORTUNITY: Chief Financial Officer, Pine
Brook, NJ / Hybrid
More
- OPPORTUNITY: Vice President, Global BD,
Remote
More
- Ovid Therapeutics: Strengthens
Executive Leadership Team to Support
Continued Pipeline Progress and Next Phase
of Development More
- Slone Partners: How to De-Risk
Executive Hiring Decisions in Life Sciences
and Healthcare
More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
